Technical Analysis for AEZS - Aeterna Zentaris Inc

Grade Last Price % Change Price Change
grade F 3.56 0.00% 0.000
AEZS closed unchanged on Monday, June 24, 2019, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AEZS trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Hammer Candlestick Bullish 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -0.56%
New Downtrend Bearish -0.56%

Older signals for AEZS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.
Articles Biotechnology Biopharmaceutical Drug Development Life Sciences Peptides
Is AEZS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.43
52 Week Low 1.68
Average Volume 20,088
200-Day Moving Average 4.1987
50-Day Moving Average 4.4058
20-Day Moving Average 3.635
10-Day Moving Average 3.62
Average True Range 0.3118
ADX 27.54
+DI 24.1368
-DI 32.0618
Chandelier Exit (Long, 3 ATRs ) 3.4246
Chandelier Exit (Short, 3 ATRs ) 3.5754
Upper Bollinger Band 4.5569
Lower Bollinger Band 2.7131
Percent B (%b) 0.46
BandWidth 50.723521
MACD Line -0.2024
MACD Signal Line -0.2782
MACD Histogram 0.0758
Fundamentals Value
Market Cap 57.36 Million
Num Shares 16.1 Million
EPS -1.71
Price-to-Earnings (P/E) Ratio -2.08
Price-to-Sales 42.62
Price-to-Book 5.01
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.710
Resistance 3 (R3) 3.707 3.653 3.685
Resistance 2 (R2) 3.653 3.615 3.655 3.677
Resistance 1 (R1) 3.607 3.592 3.630 3.610 3.668
Pivot Point 3.553 3.553 3.565 3.555 3.553
Support 1 (S1) 3.507 3.515 3.530 3.510 3.452
Support 2 (S2) 3.453 3.492 3.455 3.443
Support 3 (S3) 3.407 3.453 3.435
Support 4 (S4) 3.410